Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02214459 · ClinicalTrials.gov registry record · NA
Dietary Approaches to Stopping Hypertension (DASH) Mobile App Pilot
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02214459 is a NA study that has completed, run by Boston University. The registered enrollment target is 24 participants.
The verdict
NCT02214459, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The enormous burden of hypertension (HTN) creates a need for effective, scalable, low risk interventions. The DASH program of diet and exercise based lifestyle change is the most well-established, evidence-based behavioral intervention to control HTN. Its recommendations are central to HTN control national guidelines and consumer health products aimed at behavioral management of HTN. However, translating these recommendations into population-wide, inexpensive, sustainable programs have to date proven largely unrealized. The objective of the proposed study is to determine the efficacy of a HTN intervention behavior change platform, 'DASH Mobile', in which patients with HTN receive counseling about the DASH diet, physical activity and HTN related behaviors from health coaches trained in evidenced-based behavioral counseling methods. DASH mobile has two primary components: 1) a smartphone app that captures patients' behavioral data using intuitive self-tracking for DASH diet intake and Bluetooth wireless sensors for blood pressure, weight and physical activity and 2) a web-based coaching portal through which health coaches view and respond to patients' behavioral data and assist them in setting goals for changing behaviors consistent with their HTN behavior change plan. We aim to conduct a pilot trial of 30 HTN patients to determine improvement from baseline to 3-month follow-up in physiological (blood pressure, weight); behavioral (diet \& physical activity); and psychological (e.g., quality of life) measures over a 3-month intervention. Completing this research will result in preliminary feasibility and efficacy data for a larger randomized efficacy trial.
Interventions
- BEHAVIORAL DASH Mobile mhealth enhanced coaching
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02214459
The ClinicalTrials.gov registry entry for NCT02214459 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DASH Mobile mhealth enhanced coaching is the first listed.
NCT02214459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02214459 about?
NCT02214459 is a clinical study titled "Dietary Approaches to Stopping Hypertension (DASH) Mobile App Pilot". The enormous burden of hypertension (HTN) creates a need for effective, scalable, low risk interventions. The DASH program of diet and exercise based lifestyle change is the most well-established, evidence-based behavioral intervention to control HTN. Its recommendations are central to HTN control n...
What is the current status of trial NCT02214459?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-07. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02214459?
The interventions under investigation include: DASH Mobile mhealth enhanced coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT02214459?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.